{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNon-coding RNAs have emerged as key regulators in human carcinogenesis, with YRNAs—a family that includes RNY1—gaining attention due to their potential role as diagnostic biomarkers in various malignancies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In this context, RNY1, as a member of the YRNA family, may be involved in the modulation of cellular processes that contribute to tumorigenesis and, thus, represents a promising candidate for further investigation in cancer biology.\n"}]}, {"type": "t", "text": "\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent evidence has highlighted the importance of non-coding RNAs in cancer, suggesting that dysregulation of these molecules can serve as an early indicator of malignant transformation. Although YRNAs have been studied in several types of cancer, the specific function and clinical utility of RNY1—particularly in urinary bladder cancer—remain to be fully elucidated."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " This gap in knowledge underscores the need for further research into whether RNY1 could improve early detection, prognostication, or therapeutic targeting.\n"}]}, {"type": "t", "text": "\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOverall, the current findings provide a rationale for exploring RNY1 as a biomarker and a regulatory molecule in carcinogenesis. Elucidating its mechanistic roles could not only aid in enhancing diagnostic strategies but also contribute to our understanding of the molecular underpinnings of cancer, paving the way for more personalized treatment approaches."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yuri Tolkach, Anna Franziska Stahl, Eva-Maria Niehoff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "YRNA expression predicts survival in bladder cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-017-3746-y"}], "href": "https://doi.org/10.1186/s12885-017-3746-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29126388"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29126388"}]}]}]}